(Adds details, background) By Lewis Krauskopf Feb 10 (Reuters) - U.S. health regulators issued recommendations to manufacturers to ensure the safe production of the blood-clot prevention drug heparin, four years after a contamination involving the widely used product set off concerns about the global pharmaceutical supply chain. The draft guidance, posted on the website of the Food and Drug Administration, is designed to help manufacturers of active ingredients, finished products and others better control heparin to avoid contamination.
Fda Issues Plan To Avoid Heparin Contamination
The Huffington Post News Editors, Huffington Post
Fri, 02/10/2012 - 9:39am
Topics: lewis krauskopf feb reuters u.s food drug administration baxter international inc u.s china reporting krauskopf john wallace dave zimmerman)read video lewis krauskopf fda oscs avoid heparin contamination agency concerns guidance document recommendations manufacturers contaminant ingredients crude production set involving potential products derived substitution active adulteration contaminated appears intentional
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more